Manufacturer
95 recalls in our database name Fresenius Kabi USA, LLC as the manufacturing or recalling firm.
Of the 95 recalls from Fresenius Kabi USA, LLC we have scored against our rubric, 8 (8%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 34 (36%) are Severe.
Which agencies issued them
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Fresenius Kabi USA is recalling sodium acetate injection due to the presence of particulate matter composed of carbon, oxygen, iron, and trace elements in multiple lots distributed nationwide.
Fresenius Kabi USA LLC is recalling 963,000 vials of Morphine Sulfate Injection because some vials are cracked, which compromises sterility assurance. The affected product was distributed nationwide.
Fresenius Kabi USA LLC is recalling Xylocaine-MPF with Epinephrine 1:200,000 injection vials nationwide due to low out-of-specification results for epinephrine assay.
Fresenius Kabi is recalling specific vials of Ketorolac Tromethamine Injection because particulate matter was found in reserve samples.
Fresenius Kabi is recalling 490,633 vials of Ketorolac Tromethamine Injection because particulate matter was found in reserve samples.
Fresenius Kabi is recalling 4,411 trays of Sensorcaine (Bupivacaine HCl and Epinephrine) because the epinephrine component tested below specification.
Fresenius Kabi is recalling 13,525 bottles of Dexmedetomidine HCl Injection due to cross-contamination with trace amounts of lidocaine.
Fresenius Kabi is recalling Doxorubicin Hydrochloride Injection vials because testing found trace amounts of octreotide.
Fresenius Kabi is recalling specific lots of Dexmedetomidine HCl Injection due to trace amounts of lidocaine contamination.
Fresenius Kabi USA, LLC is recalling 63,067 vials of Fosaprepitant for Injection because carton labels and product inserts incorrectly state the amount of the excipient edetate disodium (EDTA).
Fresenius Kabi is recalling specific lots of Ketorolac Tromethamine Injection because particulate matter was found in reserve sample vials.
Fresenius Kabi is recalling specific lots of Ketorolac Tromethamine Injection because particulate matter was found in reserve sample vials.
Fresenius Kabi USA, LLC is recalling 14,016 vials of Fluorouracil Injection due to the presence of glass particulates.
Fresenius Kabi USA, LLC is recalling 11,981 vials of Ondansetron Injection, USP, 40 mg / 20 mL, because the product failed impurities and degradation specifications.
Fresenius Kabi is recalling 23.7 million sodium chloride vials because labels incorrectly state the stoppers do not contain natural rubber latex.
Fresenius Kabi is recalling 1,312,350 vials of Sodium Chloride Injection because labels incorrectly state the stoppers do not contain natural rubber latex.
Fresenius Kabi USA is recalling 35,620 vials of Vecuronium bromide for Injection due to an out-of-specification result for a related compound.
Fresenius Kabi is recalling 203,136 syringes of Midazolam Injection that were mislabeled and actually contain Ondansetron Injection.
Fresenius Kabi USA is recalling 118,224 vials of Fluphenazine Decanoate Injection because the drug was found to be subpotent.
Fresenius Kabi is recalling specific lots of Midazolam Injection because they failed impurities and degradation specifications.
Fresenius Kabi is recalling specific lots of Sensorcaine injection because glass particulate matter was found in the sterile product.
Fresenius Kabi USA is recalling Octreotide Acetate Injection vials because they failed impurities and degradation specifications.
Fresenius Kabi is recalling specific lots of Octreotide Acetate Injection because they failed impurities and degradation specifications.
Fresenius Kabi is recalling 94,560 vials of Cisatracurium Besylate Injection because the carton labels incorrectly state the product is preservative-free.
Fresenius Kabi USA, LLC is recalling Haloperidol Decanoate Injection due to an impurity out-of-specification result. The recall affects 48,210 units distributed nationwide and in Puerto Rico.
Community-sourced company facts from Wikidata, not from any recall agency. This is background on the corporate entity — it says nothing about the recall(s) listed on this page, which come from the agency source notice above.
Fresenius Kabi
company based in Bad Homborg, Germany; offers health products for the critically and chronically ill.
Source: Wikidata (Q1455670), licensed CC0. Wikidata is community-edited and may not reflect the current corporate structure.